Northrop Grumman Stock Slips After Q4 Revenue Miss, Moderate FY22 Outlook; Boosts Buyback

  • Northrop Grumman Corp NOC reported a fourth-quarter FY21 sales decline of 15% year-over-year to $8.64 billion, -10% on an organic basis, missing the consensus of $8.99 billion.
  • Sales by segments: Aeronautics Systems $2.63 billion (-25% Y/Y), Defense Systems $1.38 billion (-28% Y/Y), Mission Systems $2.52 billion (-8% Y/Y), and Space Systems $2.66 billion (+4% Y/Y).
  • The company attributed the lower Q4 sales, in part, to a $583 million reduction in sales related to the IT services divestiture.
  • Adjusted EPS was $6.00, a decline from $6.59 in 4Q20, beating the consensus of $5.99.
  • Total operating income fell by 36% Y/Y to $742 million, and the margin contracted by 270 bps to 8.6%, while the segment operating margin was flat at 11.2%.
  • Northrop Grumman generated cash from operating activities for FY21 of $3.57 billion, compared to $4.31 billion a year ago, with an adjusted Free cash flow of $2.24 billion (-39% Y/Y).
  • The company's backlog was $76 billion as of December 31, 2021. Net awards in the quarter totaled $9.8 billion.
  • Buyback: Northrop Grumman's board increased share repurchase authorization by $2 billion, bringing the total outstanding authorization up to $4.2 billion.
  • FY22 Outlook: Northrop Grumman expects sales of $36.2 billion-$36.6 billion, below the consensus of $37.03 billion. Transaction adjusted EPS of $24.50 -$25.10 versus the consensus of $25.09.
  • Price Action: NOC shares traded lower by 7.37% at $373.49 on the last check Thursday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceBuybacksMoversTrading IdeasBriefswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!